Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
200k block about to fall at 25
Here comes the volume
LP certainly has the masses fooled on this one.
longs ??? me-- I got longer - added an extra 100k shares in the last week to go along with previous block
shorts-- lets hope the x-men get shorter and shorter
whenever I mention the fools who perpetually bash, my posts get removed... lol... these board monitors are cra cra
He would not leave to work for a fraudulent penny stock biotech.
He would leave to be partner to the biggest drug approval launch since KEYTRUDA and the NEXT BLOCKBUSTER drug
Just added to my future nest egg. ROTH-IRA
TIME for a move in $$
its time for the new hires to pay dividends. share price needs to breakout and run and not just a few pennies.
time for $$$$$
DUFFY AND INNES - both leave big companies for a virtual startup with no approved drug on market.
I suspect they both did their DD and see the potential future of DCVAX-
they didn't come for DIRECT. THAT is five years in the future,
dcvax-l is NOW, and its gonna happen.
I would guess they both are receiving a nice stock option gift as part of compensation that will make them quite comfortable into retirement some day
my block of shares > 150k will do me well very soon.
druggie
Seriously KABUN!! if the trial would have reached its stat sig endpoint , they would have terminated the trial long ago. You have to draw certain conclusions, yes some based on air!!! But based on an If this then that could have occurred.
I know nothing more or less than any other poster on this board. Mine is my own opinion loosely based in conjunction with similar opines from many who post here ... like flipper, doglogic, Longfellow, DR BALA etc
HAVING FOLLOWED this stock for years and owned for last two years, it’s my belief that what NWBO has learned about its drug over 10 + years in trial is what is causing a rewrite of the SAP
It is obvious to me and many that it didn’t meet the original endpoints or the trial would have been stopped
Thus it continued the trial to show the long tail of the survivors
And at 20-25% in the 3-5 year range this shows efficacy
But they didn’t have this kind of efficacy proof years ago
They do know
I am ASSUMING just like everyone who posts here, we are assuming 20% survival based on knowledge obtained from the company and then drawing conclusions as to how survival got that high since SOC is 5 % at 5 years. Using our basis and response rates of certain subgroups we ascertain some subgroups respond better .
That’s not a difficult concept and one that the board has belabored ad nauseum for 240k posts
its accurate to the point that the initial thoughts/ endpoints, responders etc on the trial initially are now determined to be wrong, invalid..
now we/ NWBO understands what the drug does, who responds etc. specialized medicine/ genomics not the old mantra.. one size fits all drugs that approvals were based on in the 70-80-90-00's
now the fda et al realized that specialized targeted medication that works on any specific subgroup is actually better for patients / payors etc than one size fits all and fails most
the SAP IS BEING CUSTOMIZED for all possibilities with an emphasis on who and why it works on X PT POPULATION
OTHERWISE the trial would have failed. the new SAP ATTEMPTS TO INSURE that the trial will succeed based on new endpoints and specific patient subgroups
KABUN... you are naïve to think that nefarious people, companies with competing interests to NWBO don't want it to FAIL.
AF, et al who have written articles, posted negatives MB posts would love to hear we failed..
I do believe we failed what was the initial trial parameters. hence why we are resubmitting our homework with a NEW AND IMPROVED SAP.
SO YES, WE are redoing our homework and have plans to customize it to the new SAP, NEW SUBGROUPS, etc that we have determined to exist in the umpteen years the trial has existed..
our hopes are the FDA IS NOT SO CROOKED as to reject us when they look at the totality of the trial, long tail or survivors etc.
many drugs in the past has been approved with a mechanism of action of unknown origin.. it just works..
we are redoing our homework now, because we are figuring out that it does work, and its works fantastically in certain subgroups
I believe the drug works, the problem is turning in your homework after the answer sheet has been distributed to the class with regards to rewriting the SAPS based on what nwbo believes to be the data.
thus hoping the FDA, the kind and benevolent organization it is, gives us a HALL PASS and overlooks all the sins of the previous trial design and lets us proof and redo our homework.
the fact that bigger and friends swallowed up 15m shares is a positive because surely they are privy to some info we are not.
ie how soon unblinding may occur. doubtful bigger et al would be buyers of $3M in stock if data unlock was TBD, not on the very near term horizon.
makes me think September will be the month
always the positive pete on the board.
NWBO is playing a zero sum game vs the shorts / naysayers on the
drug submission.
rewriting the book on how to / how not to run a clinical trial.
so much has changed since the original format of the trial was designed.
so now a rewrite of the SAP x 4 to the major fda bodies and foreign equivalents must to done. in June, we are close, homestretch to complete SAP. Since then 90 days have passed, so who is correct.
NWBO has spent 9 months working on the SAP,
are we finished yet???
should be days, hours from completion.
now nwbo is going for the KILL SHOT,
SCREW THE SHORTS, and the naysayers, bears, AF
in the perfect world all the stars align and the plan works and the powers that be look like geniuses.
I have yet to hear an explanation of how NWBO intends to pay for their share of any upcoming new trials.
My average cost is 0.26 now so any break from here to the upside will make me quite profitable.
Good luck
It will only become interesting if when we break 0.35–0.36 and run from there.
Lot of blocks moving suddenly
I missed my buys under 22 looks like no dips or cheap shares today
I will probably buy 25k between 23-24 soon I hope
I am attempting to buy some below 22 before end of day.
if we clear 23 its off to the races as longs pile in and prove the bash brothers wrong.
on twitter --bigger said he took a big piece of it, majority ?? so I would think he is own of our largest holders of common stock and warrants
I would have rather had NEW BLOOD buy the woodford shares but beggers cant be choosy.
the fact that BIGGER SWALLOWED THAT BLOCK OF 15M SHARES or vast majority shows nothing has changed in his universe, now he may have to file ownership greater than 5%, if he has more than 30M total shares?????
need to break 0.24 to the upside or we are just range bound till further news. a good push is all we need. I imagine most longs are tapped out or don't want to risk further capital.
I believe the bottom is now in 19-20 .. no need to retest
the risk to reward of being short at 0.20 is absurd.
only a fool or tool is still short at this point.
all these bashers want longs to believe they are short and still spread fud and fear to the message board to keep others from investing or encouraging weak hands to divest shares,
I have a nice block 100k shares and can afford to just wait it out and see if LINDA has the chops and will be getting us over the proverbial hump
considering how much mass dilution we have had in past 2 years,
I think its all toxic.
bigger et al basically have net zero cash invested but hold lottery warrants worth hundreds of millions when eventual success is announced
BIGGER CAP et al who have been funding NWBO the past 5 years have all been TOXIC -- hence the massive dilution with warrants-
we all like to believe everything is puppies rainbows and ice cream but I still expect another 1-3 MINOR DILUTIONS along the way till unblinding.
Since no one reads stat news otherwise they would not be begging for subscribers / unused !!!
Anyone have a link or cut n paste to AF last toilet paper
my 25K buy at the open 0.205
about time for some appreciation
true value if truly proven tech is 10-50B
until then we wait
JR bringing the heat. true feel good stories don't really move the needle and the original presumed outcome of trial was poorly written in retrospect.
fda has approved drugs based on secondary markers and this will likely be approved also once the SAPS are rewritten.
the real money to be made is on the upside on this horse.
THOSE bearish on therapies EX, IC et al will cry snake oil, etc for treatments not yet approved that didn't pass the same rigorous process as other drugs.
once proved SAFE in a large enough patient pop, oncology drugs should be fast tracked for approval based on best interest for public health and further post approval P4 trials run to confirm effectiveness and safety. this gets many more options to market faster and less costly and then lets the performance of the drug prove its worthiness compared to other meds.
YES I would have loved to surprise the misses with a trip, then tell her we won the nwbo lottery.
unfortunately we have to stick to scratch-offs. bc $nwbo refuses to pay off
flipper- DONT u mean SOC not placebo
doing your homework / with the answer key
so does this mean, we will wait till beyond NOV 2019 for nwbo to release topline data???
More innuendo IC
THEN WHAT DID U SEE ??
Enlighten us please
those that short and or naked short life saving treatments and medications like DCVAX. there is a special place down below where the fires rage and they will eventually answer for their sins against humanity.
Trump would want to take credit and say cancer cured on his watch lol
FLIP you are one of my favorite reads- but you are in left field on this buyout runway price argument IMHO
if Linda wants an early deal - then she leaves money on the table. A few BILLION
if she wants to maximize the buyout price then she waits until DCVAX-L
SAP is approved by US FDA and closer to filing BLA 6-12 months from now
Big pharma probably wants this tech in the 1-5 B range
Linda probably wants 10-25B dependent on the level of proof of concept.
I guarantee BP does the product launch and it will be one of the big boys
Merck, Roche, Amgen , Pfizer, BMY ETC
they all have the means to buyout NWBO at any price
It’s just a waiting game now IMHO
The message board attacks are ongoing / only the resurrected names return to start new FUD in attempts to dash the hopes of the faithful LONGS. If u have owned NWBO from higher prices then just stay the course
Big pharma has an ungodly large amount of cash on hand to buyout NWBO
SUPPOSEDLY Linda wouldn’t take less than 20-25B — that’s a pittance to the likes of ROCHE PFIZER MERCK BMY
Get top line data in the public eye and its gentlemen START YOUR ENGINES on the bidding
Dude
Wake up
The original SAP / the original trial endpoint PFS likely DID FAIL TO MEET ITS ENDPOINT
Hence all the wrangling over LONG TAILS and X # of survivors at 24/36/48/60 and beyond .
The current SOC survival stats are horrible. But NWBO didn’t see separation from SOC until beyond that magic line in the sand around 16 months.
Then the SOC PTS virtually all died and the crossover pts suddenly started to LIVE LONGER -
they didnt factor in an abnormally high crossover to DCVAX
THIS IS WHY THEY SUDDENLY HAVE TO REWRITE “war and peace” from the beginning to
RE- HYPOTHESIZE what they think they are seeing in the trial before/ after the fact
And must do so in a manner that the FDA , full of criminals as it is can’t help but give its blessing and allow us to file a BLA and seek approval
If all the conjecture over long tail and 80-100 pts still being alive is true - then I will give them a pass
on the FI-ASCO if they can rewrite the SAP now and get it done soon
End of summer at the latest